Copyright
©The Author(s) 2022.
World J Hepatol. May 27, 2022; 14(5): 1016-1024
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.1016
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.1016
PVT (+), n = 8 | PVT (-), n = 227 | P value | OR | 95%CI | ||
Partial resection | 2 (25.0%) | 68 (30.0%) | 0.76 | 0.78 | 0.15-3.96 | |
Segmentectomy | Left | - | 8 (3.5%) | 0.59 | ||
Right | - | 40 (17.6%) | 0.19 | |||
Sectiontectomy | Left | 5 (62.5%) | 24 (10.6%) | < 0.0001 | 14.10 | 3.17-62.71 |
Right | 1 (12.5%) | 31 (13.7%) | 0.93 | 0.90 | 0.11-7.60 | |
Hemihepatectomy | Left | - | 37 (16.3%) | 0.21 | ||
Right | - | 19 (8.4%) | 0.39 |
- Citation: Yoshida N, Yamazaki S, Masamichi M, Okamura Y, Takayama T. Prospective validation to prevent symptomatic portal vein thrombosis after liver resection. World J Hepatol 2022; 14(5): 1016-1024
- URL: https://www.wjgnet.com/1948-5182/full/v14/i5/1016.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i5.1016